The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.

Researchers have revealed for the first time how a key protein linked to Parkinson's mutates, leads to cell death in the ...

Dr. Yang Jian, leader of the team that published the Nature article unveiling a new method known simply as "gsMap" Photo: ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

Call your Delaware senators and representatives and tell them to continue to support science through funding to the NIH and NSF.

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

The Foundation’s National Volunteer Advocacy Committee provides guidance and support to further strengthen and enhance the ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

Study reveals the structure of PINK1 protein, offering fresh hope for Parkinson's patients through potential targeted therapies that address root causes.

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

LISCure Biosciences Inc. ('LISCure') announced on the 2025 Feb that it has received approval from the Korean Ministry of Food and Drug Safety (KMFDS) for Mobiome®, a proprietary probiotic ingredient ...